Amprius Technologies (NYSE:AMPX) Stock Price Down 5.1% – Should You Sell?

Amprius Technologies, Inc. (NYSE:AMPX)’s stock price fell 5.1% on Tuesday . The company traded as low as $17.34 and last traded at $17.7360. 7,865,717 shares were traded during mid-day trading, a decline of 13% from the average session volume of 9,034,770 shares. The stock had previously closed at $18.68.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AMPX shares. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Oppenheimer reiterated an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Needham & Company LLC reissued a “buy” rating and set a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Cantor Fitzgerald boosted their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Finally, B. Riley Financial upped their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, March 9th. Eight analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.

Amprius Technologies Trading Down 5.1%

The stock’s 50 day moving average is $13.01 and its two-hundred day moving average is $11.62. The stock has a market capitalization of $2.43 billion, a price-to-earnings ratio of -52.16 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last released its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm had revenue of $25.23 million for the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, research analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Insider Transactions at Amprius Technologies

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares of the company’s stock, valued at approximately $9,014,299.84. This trade represents a 39.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kang Sun sold 950,548 shares of the business’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $11.07, for a total value of $10,522,566.36. Following the completion of the sale, the director owned 1,403,651 shares in the company, valued at $15,538,416.57. The trade was a 40.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,929,357 shares of company stock valued at $37,783,110 in the last ninety days. Corporate insiders own 12.90% of the company’s stock.

Institutional Trading of Amprius Technologies

A number of institutional investors have recently made changes to their positions in AMPX. Alberta Investment Management Corp bought a new position in Amprius Technologies in the fourth quarter valued at $1,001,000. Vident Advisory LLC acquired a new stake in Amprius Technologies in the 4th quarter valued at $107,000. Summit Securities Group LLC bought a new stake in Amprius Technologies during the 4th quarter worth about $54,000. Numerai GP LLC lifted its position in Amprius Technologies by 29.1% during the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock worth $759,000 after buying an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. boosted its stake in shares of Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock worth $3,589,000 after buying an additional 267,385 shares during the last quarter. Institutional investors own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.